Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-25-078627
Filing Date
2025-05-29
Accepted
2025-05-29 09:44:19
Documents
17

Document Format Files

Seq Description Document Type Size
1 424B3 may_2025_s-1_public_offe.htm 424B3 3957921
2 GRAPHIC img149997920_0.jpg GRAPHIC 11028
3 GRAPHIC img149997920_1.jpg GRAPHIC 124232
4 GRAPHIC img149997920_2.jpg GRAPHIC 147463
5 GRAPHIC img149997920_3.jpg GRAPHIC 39268
6 GRAPHIC img149997920_4.jpg GRAPHIC 147463
7 GRAPHIC img149997920_5.jpg GRAPHIC 147463
8 GRAPHIC img149997920_6.jpg GRAPHIC 120017
9 GRAPHIC img149997920_7.jpg GRAPHIC 56246
10 GRAPHIC img149997920_8.jpg GRAPHIC 40505
11 GRAPHIC img149997920_9.jpg GRAPHIC 65464
12 GRAPHIC img149997920_10.jpg GRAPHIC 97434
13 GRAPHIC img149997920_11.jpg GRAPHIC 97460
14 GRAPHIC img149997920_12.jpg GRAPHIC 50277
15 GRAPHIC img149997920_13.jpg GRAPHIC 38972
16 GRAPHIC img149997920_14.jpg GRAPHIC 39038
17 GRAPHIC img149997920_15.jpg GRAPHIC 11028
  Complete submission text file 0000950170-25-078627.txt   5660054
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-287423 | Film No.: 25998274
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)